Sardocor Overview
- Headquarters
- 6 Tide St
- Website
- www.medera.bio
- Industry
- Biotechnology Research
- Employees
- 6
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Sardocor
Sardocor, a subsidiary wholly-owned by Medera (www.linkedin.com/company/medera-biopharmaceutical), is dedicated to the clinical development of novel therapies. Building upon Novoheart’s (www.linkedin.com/company/novoheart-limited) bioengineered human tissue-based assays for disease modelling and drug discovery, Sardocor aspires to create the shortest regulatory path to the clinic for advancing effective next-generation cell & gene therapy
Sardocor Contact Details
- People in AeroLeads
- 3
Sardocor Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Sue Kim | Financial Controller at Sardocor |
View
|
|
| Navid Chapman | Sr. Project Manager at Sardocor | Philadelphia, Pennsylvania, United States |
View
|
| Lijing Li | Global Head Technical Operation, Cmc |
View
|
Employees by Management Level
Individual contributor
2 profiles
Manager
1 profile
Compare Similar Companies to Sardocor
Capricor Therapeutics, Inc.
Biotechnology Research
Solid Biosciences
Biotechnology Research
Skin and Beauty Center
Medical Practices
Xellera Therapeutics
Biotechnology Research
Carbon Biosciences
Biotechnology Research
Novoheart
Biotechnology Research
Medera Inc.
Biotechnology Research
Viage Therapeutics, Inc.
Biotechnology
Parallel Immunotherapeutics Inc.
Biotechnology Research
VasoRx, Inc.
Biotechnology Research